See All Slides - tctmd.com

Slides

Presentation TCT 2013

What Should the Adult Cardiologist Know about PDA Closure?

Presenter: John Moore

October 30, 2013

Presentation TCT 2013

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Real-Time Device Surveillance

Presenter: Mladen Vidovich

October 30, 2013

Presentation TCT 2013

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

Presenter: David Kandzari

October 30, 2013

Presentation TCT 2013

When is a Second Stent Required (Planned and Provisional)

Presenter: Goran Stankovic

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Case #3: Endovascular Repair of Abdominal Aorta Aneurysm

Presenter: Zaza Kavteladze

October 30, 2013

Presentation TCT 2013

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Presenter: Pim Tonino

October 30, 2013

Presentation TCT 2013

Starting your Structural Heart Program: Mistakes Made, Lessons Learned

Presenter: Mathew Williams

October 30, 2013

Presentation TCT 2013

Introduction: Publishing in the EHJ

Presenter: Bernard Gersh

October 30, 2013

Advertisement

Slides

What Should the Adult Cardiologist Know about PDA Closure?

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Real-Time Device Surveillance

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

When is a Second Stent Required (Planned and Provisional)

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Case #3: Endovascular Repair of Abdominal Aorta Aneurysm

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Starting your Structural Heart Program: Mistakes Made, Lessons Learned

Introduction: Publishing in the EHJ

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content